Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research. / Sheikh, Zainab Afshan; Yu, Helen.

In: Journal of Responsible Innovation, Vol. 11, No. 1, 2024.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Sheikh, ZA & Yu, H 2024, 'Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research', Journal of Responsible Innovation, vol. 11, no. 1. https://doi.org/10.1080/23299460.2024.2316363

APA

Sheikh, Z. A., & Yu, H. (2024). Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research. Journal of Responsible Innovation, 11(1). https://doi.org/10.1080/23299460.2024.2316363

Vancouver

Sheikh ZA, Yu H. Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research. Journal of Responsible Innovation. 2024;11(1). https://doi.org/10.1080/23299460.2024.2316363

Author

Sheikh, Zainab Afshan ; Yu, Helen. / Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research. In: Journal of Responsible Innovation. 2024 ; Vol. 11, No. 1.

Bibtex

@article{41fef43d6b2440139bd264f855052d20,
title = "Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research",
abstract = "Ensuring societal influence in research and innovation through stakeholder engagement is vital in the Responsible Research and Innovation (RRI) framework. By studying a drug discovery project, we examine how stakeholders can influence drug discovery and development meaningfully. Through semi-structured interviews, we explore: How do patients as potential users of a new drug, the scientists who discover it, and the industry that might develop it, think about responsibility and stakeholder engagement in drug discovery? Most of the responses voiced by our informants about responsibility and stakeholder engagement relate to the broader institutional and political context of health-related innovation, rather than the specific research project. We argue, that in order to make stakeholder engagement work within some forms of drug discovery research, it should be used as a forum for mobilizing political and organizational debate, taking critical dialogues beyond project-specific engagement in innovation.KEYWORDS: Responsible Research and Innovationstakeholder engagementdrug discoveryscience-society relationssemi-structured interviews",
author = "Sheikh, {Zainab Afshan} and Helen Yu",
year = "2024",
doi = "10.1080/23299460.2024.2316363",
language = "English",
volume = "11",
journal = "Journal of Responsible Innovation",
issn = "2329-9460",
publisher = "Routledge",
number = "1",

}

RIS

TY - JOUR

T1 - Perspectives of COPD patients, publicly funded scientists, and industry representatives on responsibility and stakeholder engagement in drug discovery research

AU - Sheikh, Zainab Afshan

AU - Yu, Helen

PY - 2024

Y1 - 2024

N2 - Ensuring societal influence in research and innovation through stakeholder engagement is vital in the Responsible Research and Innovation (RRI) framework. By studying a drug discovery project, we examine how stakeholders can influence drug discovery and development meaningfully. Through semi-structured interviews, we explore: How do patients as potential users of a new drug, the scientists who discover it, and the industry that might develop it, think about responsibility and stakeholder engagement in drug discovery? Most of the responses voiced by our informants about responsibility and stakeholder engagement relate to the broader institutional and political context of health-related innovation, rather than the specific research project. We argue, that in order to make stakeholder engagement work within some forms of drug discovery research, it should be used as a forum for mobilizing political and organizational debate, taking critical dialogues beyond project-specific engagement in innovation.KEYWORDS: Responsible Research and Innovationstakeholder engagementdrug discoveryscience-society relationssemi-structured interviews

AB - Ensuring societal influence in research and innovation through stakeholder engagement is vital in the Responsible Research and Innovation (RRI) framework. By studying a drug discovery project, we examine how stakeholders can influence drug discovery and development meaningfully. Through semi-structured interviews, we explore: How do patients as potential users of a new drug, the scientists who discover it, and the industry that might develop it, think about responsibility and stakeholder engagement in drug discovery? Most of the responses voiced by our informants about responsibility and stakeholder engagement relate to the broader institutional and political context of health-related innovation, rather than the specific research project. We argue, that in order to make stakeholder engagement work within some forms of drug discovery research, it should be used as a forum for mobilizing political and organizational debate, taking critical dialogues beyond project-specific engagement in innovation.KEYWORDS: Responsible Research and Innovationstakeholder engagementdrug discoveryscience-society relationssemi-structured interviews

U2 - 10.1080/23299460.2024.2316363

DO - 10.1080/23299460.2024.2316363

M3 - Journal article

VL - 11

JO - Journal of Responsible Innovation

JF - Journal of Responsible Innovation

SN - 2329-9460

IS - 1

ER -

ID: 384417528